In vitro activities of OPC-17116, a new quinolone; ofloxacin; and sparfloxacin against Chlamydia pneumoniae.

Roblin, P M; Montalban, G; Hammerschlag, M R

Name:

aac.38.6.1402.pdf

Size:

350.7Kb

Format:

PDF

Download

Cast your vote
You can rate an item by clicking the amount of stars they wish to award to this item. When enough users have cast their vote on this item, the average rating will also be shown.

Star rating

Your vote was cast
Thank you for your feedback

Author

Roblin, P M
Montalban, G
Hammerschlag, M R

Journal title

Antimicrobial agents and chemotherapy

Date Published

1994-06

Publication Volume

Publication Issue

Publication Begin page

1402

Publication End page

Metadata

Show full item record

URI

http://hdl.handle.net/20.500.12648/10336

Abstract

The in vitro susceptibilities of 12 strains of Chlamydia pneumonia to a new quinolone, OPC-17116; ofloxacin; and sparfloxacin were determined. OPC-17116 was slightly less active than sparfloxacin but more active than ofloxacin, with a MIC for 90% of strains tested and a minimal chlamydiacidal concentration for 90% of strains tested of 0.5 micrograms/ml.

Citation

Roblin PM, Montalban G, Hammerschlag MR. In vitro activities of OPC-17116, a new quinolone; ofloxacin; and sparfloxacin against Chlamydia pneumoniae. Antimicrob Agents Chemother. 1994 Jun;38(6):1402-3. doi: 10.1128/AAC.38.6.1402. PMID: 8092845; PMCID: PMC188218.

Collections

Downstate College of Medicine

The following license files are associated with this item:

Creative Commons

Except where otherwise noted, this item's license is described as Attribution-NonCommercial-NoDerivatives 4.0 International